Deep-Dive Due Diligence AI Generated Report on OSR Holdings, Inc. Common Stock (OSRH)
Welcome to ScanScor. What you're reading is not just a stock summary -- it's a real-time, AI-generated due diligence session crafted from live news, financial data, insider trading activity, SEC filings, and live market momentum.
These reports are generated using OpenAI's GPT-based analysis engine, guided by tightly structured prompts and expert-level data ingestion. Every insight below was assembled to help you understand the forces behind today's market movers.
Disclaimer: This report is for informational purposes only. It does not constitute financial advice. Always do your own research before making any investment.
OSRH_OUT_1 [2025-04-03 04:21:50 -0400] 1974 Bytes | 552 tokens | Cum: 552 tkns (6.90% of 8k)
==========================================================================
We are in the 'Lightning Round' baby! It's 4:21:50 AM on Thu Apr 03, 2025 -0400, and I'm firing up the spotlight on OSR (OSRH), moving from 1.47 to 1.74. Is this a can’t-miss rocket or a one-hit wonder? Let’s dissect the numbers!
--- COMPANY PROFILE ---
Company: OSR (OSRH)
IPO: 2025-02-18 (1 Month Ago)
Market Cap: $33,156,402
Shares Outstanding: 19,280,000
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Exchange: XNAS
Description: OSR Holdings Inc is a healthcare company, dedicated to healthcare outcomes and improving the quality of life for people and their families. It builds and develops a robust portfolio of and potentially transformative therapies and healthcare solutions.
Here's the first list of news for OSR:
C1 - Mar-26-25 07:16AM - Vaximm AG, an OSR Company, Announces Results from Phase 2a Trial of VXM01 and Avelumab Combination Therapy in Glioblastoma
C2 - Mar-25-25 07:00AM - OSR Holdings Appoints Dr. Constance Hfer as Chief Scientific Officer
Prior AI Reports for OSRH:
1. 2025-03-26 – Score: 20 – Target: 3.9900 – Highs: 4.3300 / 3.0400 / 2.79
struggling-company-grapples-with-significant-decline-and-high-volatility
(Note: Highs = Same day / 2nd day / 3rd day)
ONLY 3 RULES for AI:
==============
1) I am a document retrieval system. You are the analyst-investigator.
2) You can request items from my lists to get more info on OSR (OSRH)
3) AFTER requesting and reading News and SEC filings you'll write a summary, set a score, high price target and headline.
Now, your response should be only 2 or 3 chars. You can say ex., C1, C2, etc., or NEX
The NEX command delivers the NEXt list of News/SEC/Metrics
There are several more lists that use our unified document retrieval system in subsequent prompts.
Your predictons will be compared to reality to rate your accuracy. Try to predict accurately. GOOD LUCK!
Please request a document, read, summarize and score. Say something like "C1".
OSRH_IN_2 [2025-04-03 04:21:50 -0400] 2 Bytes | 2 tokens | Cum: 554 tkns (6.93% of 8k)
==========================================================================
C1
OSRH_OUT_3 [2025-04-03 04:21:54 -0400] 1103 Bytes | 318 tokens | Cum: 872 tkns (10.90% of 8k)
==========================================================================
Showing C1 (chunk 1 of 6): C1:
**Vaximm AG, an OSR Company, Announces Results from Phase 2a Trial of VXM01 and Avelumab Combination Therapy in Glioblastoma**
Date: Mar-26-25 07:16AM
Source: (PR Newswire)
URL: https://www.prnewswire.com/news-releases/vaximm-ag-an-osr-company-announces-results-from-phase-2a-trial-of-vxm01-and-avelumab-combination-therapy-in-glioblastoma-302411928.html
Results from Phase 2a Trial demonstrate a good safety and tolerability profile of VXM01 and Avelumab Combination Therapy in Glioblastoma, supporting further investigation of VXM01
BASEL, Switzerland,March 26, 2025/PRNewswire/ -- Vaximm AG, a subsidiary of OSR Holdings, Inc. and a pioneering biotechnology company focused on developing innovative immunotherapies, today announced final data from the successful conclusion of its open-label Phase 2a clinical trial assessing the safety and tolerability of VXM01, an investigational oral ant
--> You can ask for 1) More of this item with: MOR, 2) the NEXt section with: NEX, or 3) a different item by it's handle (ex. C3, S2) (only 3 chars don't summarize yet)
OSRH_IN_4 [2025-04-03 04:21:54 -0400] 274 Bytes | 62 tokens | Cum: 934 tkns (11.68% of 8k)
==========================================================================
Vaximm AG, a subsidiary of OSR Holdings, has announced successful results from its Phase 2a clinical trial for VXM01 and Avelumab combination therapy in treating Glioblastoma. The data showed a good safety and tolerability profile, supporting further investigation of VXM01.
OSRH_OUT_5 [2025-04-03 04:21:55 -0400] 988 Bytes | 299 tokens | Cum: 1233 tkns (15.41% of 8k)
==========================================================================
We present this news so you can catch the big movers from recently breaking news.
Here's a list of news articles you can literally read just by asking.
Usually the first item is the most important.
A1 - 2025-03-27T17:05:46Z - 12 Health Care Stocks Moving In Thursday's Intraday Session - AquaBounty Techs (NASDAQ:AQB), CervoMe...
A2 - 2025-03-27T13:21:52Z - Pre-market Movers: GTEC, SLNO, RGLS, OSRH, SNX......
A3 - 2025-03-27T12:05:52Z - 12 Health Care Stocks Moving In Thursday's Pre-Market Session - Anebulo Pharmaceuticals (NASDAQ:ANEB...
A4 - 2025-03-27T09:56:50Z - Why Greenland Technologies Shares Are Trading Higher By Around 89%; Here Are 20 Stocks Moving Premar...
A5 - 2025-03-26T21:05:44Z - 12 Health Care Stocks Moving In Wednesday's After-Market Session - Acrivon Therapeutics (NASDAQ:ACRV...
Request an article by its reference number. (Ex., "A1" gets the first item)
You may also say NEX to go to the next listing.
Response to this prompt limited to 3 chars.
OSRH_IN_6 [2025-04-03 04:21:55 -0400] 2 Bytes | 2 tokens | Cum: 1235 tkns (15.44% of 8k)
==========================================================================
A1
OSRH_OUT_7 [2025-04-03 04:21:56 -0400] 1098 Bytes | 340 tokens | Cum: 1575 tkns (19.69% of 8k)
==========================================================================
Showing A1 (chunk 1 of 3): A1:
**12 Health Care Stocks Moving In Thursday's Intraday Session - AquaBounty Techs (NASDAQ:AQB), CervoMed (NASDAQ:CRVO)**Date: 2025-03-27Source: {'uri': 'benzinga.com', 'dataType': 'news', 'title': 'Benzinga'}URL: https://www.benzinga.com/insights/movers/25/03/44520201/12-health-care-stocks-moving-in-thursdays-intraday-sessionGainers 23andMe Holding ME stock increased by 79.1% to $0.95 during Thursday's regular session. The market value of their outstanding shares is at $25.4 million. Nkarta NKTX stock increased by 55.41% to $2.13. The company's market cap stands at $150.2 million. As per the news, the Q4 earnings report came out yesterday. Regulus Therapeutics RGLS stock moved upwards by 53.87% to $1.99. The market value of their outstanding shares is at $131.4 million. Soleno Therapeutics SLNO shares increased by 43.33% to $70.19. The company's market cap stands at $3.0 billion. Cerv
--> You can ask for 1) More of this item with: MOR, 2) the NEXt section with: NEX, or 3) a different item by it's handle (ex. C3, S2) (only 3 chars don't summarize yet)
OSRH_IN_8 [2025-04-03 04:21:56 -0400] 3 Bytes | 2 tokens | Cum: 1577 tkns (19.71% of 8k)
==========================================================================
MOR
OSRH_OUT_9 [2025-04-03 04:21:56 -0400] 1098 Bytes | 338 tokens | Cum: 1915 tkns (23.94% of 8k)
==========================================================================
Showing A1 (chunk 2 of 3): oMed CRVO stock rose 29.05% to $9.95. The market value of their outstanding shares is at $86.5 million. Tenon Medical TNON shares rose 21.52% to $2.94. The company's market cap stands at $9.2 million. Losers AquaBounty Techs AQB shares declined by 29.7% to $0.72 during Thursday's regular session. The market value of their outstanding shares is at $2.7 million. Equillium EQ shares declined by 26.14% to $0.56. The market value of their outstanding shares is at $19.8 million. OSR Holdings OSRH shares declined by 23.49% to $2.9. The company's market cap stands at $55.9 million. EXoZymes EXOZ shares decreased by 16.82% to $10.49. The company's market cap stands at $99.9 million. Petros Pharma PTPI stock decreased by 16.52% to $0.11. The market value of their outstanding shares is at $2.8 million. Longevity Health Holdings XAGE shares fell 16.18% to $0.14. The company's market cap stands at $4
--> You can ask for 1) More of this item with: MOR, 2) the NEXt section with: NEX, or 3) a different item by it's handle (ex. C3, S2) (only 3 chars don't summarize yet)
OSRH_IN_10 [2025-04-03 04:21:56 -0400] 3 Bytes | 2 tokens | Cum: 1917 tkns (23.96% of 8k)
==========================================================================
NEX
OSRH_OUT_11 [2025-04-03 04:21:57 -0400] 267 Bytes | 67 tokens | Cum: 1984 tkns (24.80% of 8k)
==========================================================================
This is our final list of news.
News AI can literally read just by asking.
Don't miss the breaking news!
Request an article by its reference number. (Ex., "B1" gets the first item)
You can say NEX to go to the next listing.
Response limited to 3 chars.
OSRH_IN_12 [2025-04-03 04:21:57 -0400] 3 Bytes | 2 tokens | Cum: 1986 tkns (24.82% of 8k)
==========================================================================
NEX
OSRH_OUT_13 [2025-04-03 04:21:58 -0400] 1123 Bytes | 292 tokens | Cum: 2278 tkns (28.48% of 8k)
==========================================================================
This is our list of SEC filings.
If empty, the search returned no recent filings.
S1 - 2025-02-27 8-K Item1.01. Entry into a Material Definitive Agrmt.
Common Stock Purchase Agrmt
On February 25, 2025, OSR Holdings, Inc. (the Company) entered into a common stock purchase agreement (the Common Stock Purchase Agrmt) and a related registration rights agreement (the Wh...
S2 - 2025-02-27 8-K Item1.01. Entry into a Material Definitive Agrmt.
Common Stock Purchase Agrmt
On February 25, 2025, OSR Holdings, Inc. (the Company) entered into a common stock purchase agreement (the Common Stock Purchase Agrmt) and a related registration rights agreement (the Wh...
S3 - 2025-02-21 8-K Item 1.01. Entry into a Material Definitive Agrmt.
Participating Joinders
Prior to the Closing Date, the Company entered into participating joinders (the Participating Joinders ) with the Participating Stockholders, pursuant to which the Company issued an aggregate of 16,...
Request filing by its reference number. (Ex., "S1" gets the first item)
You can say NEX to go to the next listing.
Response limited to 3 chars.
OSRH_IN_14 [2025-04-03 04:21:58 -0400] 2 Bytes | 2 tokens | Cum: 2280 tkns (28.50% of 8k)
==========================================================================
S1
OSRH_OUT_15 [2025-04-03 04:22:01 -0400] 1098 Bytes | 262 tokens | Cum: 2542 tkns (31.77% of 8k)
==========================================================================
Showing S1 (chunk 1 of 5): S1:
Item1.01. Entry into a Material Definitive Agreement.
Common Stock Purchase Agreement
On February 25, 2025, OSR Holdings, Inc. (the Company) entered into a common stock purchase agreement (the Common Stock Purchase Agreement) and a related registration rights agreement (the White Lion RRA) with White Lion GBM Innovation Fund (White Lion). Capitalized terms used but not defined herein shall have the meanings ascribed to such terms in the Common Stock Purchase Agreement.
Pursuant to the Common Stock Purchase Agreement, following its closing and following the effective date of a resale registration statement registering the shares issuable to White Lion in accordance with the terms of the White Lion RRA, the Company has the right, but not the obligation, to require White Lion to purchase, from time to time, up to the lesser of (i) $80,000,000 in aggregate gross purchase price of new
--> You can ask for 1) More of this item with: MOR, 2) the NEXt section with: NEX, or 3) a different item by it's handle (ex. C3, S2) (only 3 chars don't summarize yet)
OSRH_IN_16 [2025-04-03 04:22:01 -0400] 394 Bytes | 83 tokens | Cum: 2625 tkns (32.81% of 8k)
==========================================================================
S1:
OSR Holdings, Inc. has entered into a Common Stock Purchase Agreement and a related registration rights agreement with White Lion GBM Innovation Fund on February 25, 2025. According to the agreement, after its closure and the effective date of a resale registration statement, OSR Holdings may require White Lion to purchase up to $80,000,000 in aggregate gross purchase price of new stock.
OSRH_OUT_17 [2025-04-03 04:22:10 -0400] 3352 Bytes | 832 tokens | Cum: 3457 tkns (43.21% of 8k)
==========================================================================
This is our set of metrics.
Please analyze the numbers.
+--------------------+-----------------------+------------------------+-------------------+
| Volume: 208,353 | Perf Month: -35.53% | Option/Short: No / Yes | Sales Y/Y TTM: - |
+--------------------+-----------------------+------------------------+-------------------+
| Avg Volume: 3.43M | Perf Quarter: -86.90% | Short Float: - | ROE: -1.13% |
+--------------------+-----------------------+------------------------+-------------------+
| Rel Volume: 0.06 | Index: - | Short Ratio: 0.02 | ROI: -3.18% |
+--------------------+-----------------------+------------------------+-------------------+
| RSI (14): 38.03 | Market Cap: 28.34M | Short Interest: 0.06M | Sales Surprise: - |
+--------------------+-----------------------+------------------------+-------------------+
| ATR (14): 0.71 | Shs Outstand: 4.04M | Beta: 1.43 | EPS Surprise: - |
+--------------------+-----------------------+------------------------+-------------------+
| SMA20: -23.27% | Shs Float: - | Sales Q/Q: - | P/E: - |
+--------------------+-----------------------+------------------------+-------------------+
| SMA50: -71.83% | Inst Own: 0.35% | Sales past 5Y: - | Earnings: - |
+--------------------+-----------------------+------------------------+-------------------+
| SMA200: -84.41% | Insider Own: - | Employees: - | |
+--------------------+-----------------------+------------------------+-------------------+
| Perf Week: -61.21% | Insider Trans: - | Debt/Eq: 0.12 | |
+--------------------+-----------------------+------------------------+-------------------+
The next section covers any insider trading.
If this section may be blank due to no recent filings.
No transactions recorded.
No transactions recorded.
No transactions recorded.
No transactions recorded.
No transactions recorded.
No transactions recorded.
[Company Financial Summary]
[Company Details]
Name: N/A
Market Cap: N/A
Shares Outstanding: N/A
Sector: N/A
[Financial Statements - Latest Quarter]
Total Assets: N/A
Total Liabilities: N/A
Total Equity: N/A
Revenue (Quarter): N/A
Net Income: N/A
Earnings Per Share (EPS): N/A
[Price Metrics - Last 30 Days]
Latest Close: 1.47
Average Volume: 4583905.95
30-Day High: 3.79
30-Day Low: 1.3305
No detailed financial data available.
==== END OF FINANCIAL REPORT ====
You are now requested to make a summary analysis.
Save explaining why you didn't have enough information for the final survey.
Now, complete this report with the following:
1) Brief Summary: explain your findings in succinct wording.
2) MARKET_SCORE: If you calculate a 92% likelihood of an upward moves, say: MARKET_SCORE[92]
3) PRICE_TARGET: If you think the high today will be 50% higher, add to the price.
Eg., If the current price is $5.00, add 50%. Thus, PRICE_TARGET[$7.50] -- It should be at or above the current price.
4) Provide a thought-provoking take, 6-10 words, to use for the headline of this news story.
Like this: AI_RPT_HEADLINE: [6-12 words headline for news story, distilled from summary]
1) Brief Summary, 2) MARKET_SCORE, 3) PRICE_TARGET, and 4) AI_RPT_HEADLINE
OSRH_IN_18 [2025-04-03 04:22:10 -0400] 1135 Bytes | 228 tokens | Cum: 3685 tkns (46.06% of 8k)
==========================================================================
1) Brief Summary:
The provided metrics indicate a challenging period for the company with a significant drop in performance over the past month (-35.53%) and quarter (-86.90%). Trading volumes are also lower than the average, indicating low investor interest. The company's negative ROE and ROI suggest poor efficiency in generating profits from its investments. Also, there's a notable short interest, indicating that some investors are expecting the price to fall further. However, due to the absence of critical data such as Sales, Earnings, and more detailed financial information, a complete and thorough analysis cannot be conducted.
2) MARKET_SCORE: Given the lack of complete information and the negative trends, a conservative estimate would be MARKET_SCORE[30].
3) PRICE_TARGET: Without complete financial data and a clear understanding of the company's prospects, it's challenging to provide a reliable price target. However, considering the negative sentiment, it would be cautious to not expect a significant increase. PRICE_TARGET[$1.70].
4) AI_RPT_HEADLINE: "Company Struggles Amid Market Downturn, Caution Advised."
OSRH_OUT_19 [2025-04-03 04:22:12 -0400] 676 Bytes | 167 tokens | Cum: 3852 tkns (48.15% of 8k)
==========================================================================
Finally, if more data could have improved your confidence which would you have chosen? **Choose one option:**
-> X0 <- Nothing more would have helped my analysis
-> X1 <- More stock-specific news
-> X2 <- More SEC filings (10-K, 10-Q, 8-K) Financials, risk disclosures, and business changes
-> X3 <- More SEC Insider Trading (Form 3, 4, 5) Direct buys/sells from executives and institutions
-> X4 <- Broader sector & market news
-> X5 <- Your past analysis on similar companies (specify metrics)
-> X6 <- More financial metrics
-> X7 <- Your past analysis on this exact company
-> X8 <- Something altogether different (explain...)
OSRH_IN_20 [2025-04-03 04:22:12 -0400] 94 Bytes | 28 tokens | Cum: 3880 tkns (48.50% of 8k)
==========================================================================
-> X2 <- More SEC filings (10-K, 10-Q, 8-K) Financials, risk disclosures, and business changes
OSRH_IN_21 [2025-04-03 04:22:13 -0400] 126 Bytes | 29 tokens | Cum: 3909 tkns (48.86% of 8k)
==========================================================================
====================================
[2025-04-03 04:22:13] # Analysis Completed
Elapsed Time: 23.13 seconds